首页|阿仑膦酸钠治疗类风湿关节炎合并骨质疏松的疗效及对骨代谢的影响

阿仑膦酸钠治疗类风湿关节炎合并骨质疏松的疗效及对骨代谢的影响

扫码查看
目的 研究阿仑膦酸钠对类风湿关节炎并发骨质疏松的作用及其对骨代谢相关情况的影响。方法 将2021年1月至2022年12月在浙江省荣军医院治疗的112例类风湿关节炎合并骨质疏松患者按治疗方法分为观察组和对照组。对照组用柳氮磺吡啶加钙剂治疗,在对照组的治疗基础上观察组加用阿仑膦酸钠进行治疗,监测和比较2组患者的治疗效果和骨代谢情况。结果 治疗后,观察组的总体疗效(71%)高于对照组(52%,x2=8。797,P=0。001);与治疗前相比,治疗后的2组关节功能均提高,且治疗后观察组的关节功能优于对照组(Z=2。147,P<0。05);与治疗前相比,治疗后的2组红细胞沉降率(ESR)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、类风湿因子(RF)均降低,且治疗后的相关炎症指标观察组低于对照组[(14。7± 2。3)mm/1 h 和(20。8±3。9)mm/1h、(10。3±1。4)mg/L 和(16。1±1。7)mg/L、(13。1±2。4)pg/ml 和(24。1±3。4)pg/ml、(21。8±2。8)U/ml 和(32。6±3。1)U/ml,t=8。197、9。762、14。741、11。626,P均<0。05];与对照组相比,治疗后的观察组骨钙素(OC)、碱性磷酸酶(ALP)、Ⅰ型前胶原氨基末端前肽(P Ⅰ NP)降低[(11。5±2。1)ng/ml和(16。2±1。7)ng/ml、(87。7±7。4)U/L 和(96。9±8。6)U/L、(53。8±5。6)ng/ml 和(61。3±6。2)ng/ml],骨密度(BMD)水平[(0。74±0。20)g/cm3和(0。55±0。11)g/cm3]升高(t=12。267、4。325、10。174、8。993,P<0。05)。结论 阿仑膦酸钠联合用药能够有效提高类风湿关节炎并发骨质疏松患者治疗的总有效率、提高关节功能、减轻炎症反应,改善患者的骨代谢状况。
Effect of alendronate sodium on rheumatoid arthritis combined with osteoporosis and its influence on bone metabolism
Objective To explore the effect of alendronate sodium on rheumatoid arthritis complicated with osteoporosis and its effect on bone metabolism.Methods The 112 patients with rheumatoid arthritis com-bined with osteoporosis who were treated in Zhejiang Veteran Hospital from January 2021 to December 2022 were divided into the observation group and the control group according to the randomized numerical table method.The control group was treated with salazopyridine combined with calcium,and the observation group was treated with alendronate sodium on the basis of the control group.The therapeutic effect and bone metabolism of the two groups were monitored and compared.Results After treatment,the overall efficacy of the observation group(71%)was higher than that of the control group(52%)(x2=8.797,P=0.001);compared with before treatment,the joint function of both groups was improved after treatment,and the joint function of the observation group was bet-ter than that of the control group after treatment(Z=2.147,P<0.05);compared with the pretreatment,the ESR,CRP,TNF-α,and RF levels were reduced in both groups after treatment,and the related inflammatory indexes after treatment were lower in the observation group than in the control group[(14.7±2.3)mm/1 h)vs(20.8±3.9)mm/1 h,(10.3±1.4)mg/L vs(16.1±1.7)mg/L,(13.1±2.4)pg/ml vs(24.1±3.4)pg/ml,(21.8±2.8)U/ml vs(32.6±3.1)U/ml,t=8.197、9.762、14.741、11.626,P<0.05];compared with the control group,the OC,ALP,and P1NP levels[(1 1.5±2.1)ng/ml vs(16.2±1.7)ng/ml、(87.7±7.4)U/L vs(96.9±8.6)U/L、(53.8±5.6)ng/ml vs(61.3±6.2)ng/ml]were reduced and the BMD level[(0.74±0.20)g/cm3 vs(0.55±0.11)g/cm3]was increased in obsevration groups after treatment(t=12.267、4.325、10.174、8.993,P<0.05).Conclusion On the basis of salazopyridine combined with conventional treatment,alendronate sodium can effectively improve the treatment efficiency,improve joint function,reduce in-flammation,improve bone metabolism of patients with rheumatoid arthritis complicated with osteoporosis.

Alendronate sodiumArthritis,rheumatoidOsteoporosisTreatment outcome

李建兰、孙贤杰、李玉

展开 >

浙江省荣军医院检验科,浙江嘉兴 314000

浙江省荣军医院骨科,浙江嘉兴 314000

浙江省荣军医院药剂科,浙江嘉兴 314000

阿仑膦酸钠 关节炎,类风湿 骨质疏松 治疗效果

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(4)
  • 22